Research suggests that a protein called IRF5 may play a role in suppressing metastasis, possibly through its regulation of tumor-derived extracellular vesicles and pre-metastatic niche formation. The relationship between IRF5 and cancer is complex, with various studies exploring its interaction with other factors, including macrophages and the immune microenvironment. The exact mechanisms and potential therapeutic applications of IRF5 and related factors in cancer treatment are being investigated.